Samrat Pharmachem Ltd.
| BSE: 530125 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE103E01016 |
| BSE 00:00 | 05 Jul | 452.40 |
11.25 (2.55%) |
OPEN
449.90 |
HIGH
459.30 |
LOW
433.00 |
| NSE 05:30 | 01 Jan | Samrat Pharmachem Ltd |
| OPEN | 449.90 |
| PREVIOUS CLOSE | 441.15 |
| VOLUME | 3602 |
| 52-Week high | 578.00 |
| 52-Week low | 170.00 |
| P/E | 8.13 |
| Mkt Cap.(Rs cr) | 140 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Samrat Pharmachem Ltd. (SAMRATPHARMA) - Competition
| COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
| Sun Pharma.Inds. | 835.55 | 200,473.51 | 12,803.21 | 2,139.70 | 32,510.54 |
| Divi's Lab. | 3,610.35 | 95,836.74 | 6,798.61 | 1,954.72 | 9,297.17 |
| Cipla | 937.70 | 75,663.02 | 13,900.58 | 2,468.28 | 20,166.89 |
| Dr Reddy's Labs | 4,389.45 | 73,058.01 | 13,349.10 | 2,186.40 | 18,266.10 |
| Apollo Hospitals | 3,816.50 | 54,873.64 | 9,153.00 | 105.00 | 8,226.00 |
| Torrent Pharma. | 2,891.85 | 48,935.89 | 6,450.83 | 1,137.85 | 10,618.60 |
| Gland Pharma | 2,530.00 | 41,669.10 | 3,462.88 | 997.01 | 5,909.86 |
| Piramal Enterp. | 1,695.75 | 40,469.07 | 1,824.70 | 39.90 | 29,983.67 |
| Abbott India | 18,630.80 | 39,590.45 | 4,310.02 | 690.69 | 2,844.49 |
| Biocon | 313.70 | 37,662.82 | 2,028.40 | 280.50 | 8,024.20 |
| Zydus Lifesci. | 361.35 | 36,991.40 | 7,790.40 | 1,476.20 | 16,841.70 |
| Alkem Lab | 3,050.40 | 36,467.53 | 7,219.68 | 1,685.08 | 9,195.63 |
| Max Healthcare | 366.45 | 35,532.09 | 1,079.68 | -164.45 | 6,439.88 |
| Aurobindo Pharma | 533.30 | 31,246.05 | 15,823.68 | 3,112.91 | 19,952.13 |
| Lupin | 627.40 | 28,521.60 | 11,055.93 | 1,258.62 | 19,354.36 |
| Glaxosmi. Pharma | 1,541.40 | 26,112.86 | 3,217.51 | 1,690.53 | 2,948.24 |
| Laurus Labs | 463.30 | 24,895.43 | 4,707.04 | 750.09 | 5,178.13 |
| Ipca Labs. | 927.90 | 23,540.82 | 5,139.16 | 1,140.77 | 5,028.39 |
| Syngene Intl. | 550.85 | 22,112.77 | 2,601.40 | 393.80 | 4,609.20 |
| Pfizer | 4,112.55 | 18,814.92 | 2,238.55 | 497.61 | 2,494.06 |
Quick Links for Samrat Pharmachem:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
